The Korea Pharmaceutical Manufacturers Association decided to keep the Exclusive Sales Rights…small and mid-sized pharmaceutical companies blew up with sadness

While the Korea Pharmaceutical Manufacturers Association (KPMA) has made its decision over the Exclusive Sale Rights, it seems that small and mid-sized pharmaceutical companies have shown sadness on the decision.

On the 10^th, the KPMA has made its clear decision to keep the Exclusive Sales Rights of the Patent Linkage System through the recommendation turned in to the National Assembly. Decidi...